Online Supplement to AJP-Lung_Chemical Power in ARDS cohort
Thijs A. Lilien, Reinout Bem, Ignacio Martín‐Loeches(St. James's Hospital), Siebe G. Blok, Michela Botta(Amsterdam University Medical Centers), Eddy Fan(University Health Network), Antonio Pesenti(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Ana Motos, Antoni Torres(Centro de Investigación Biomédica en Red de Enfermedades Respiratorias), Ary Serpa-Neto, Tai Pham, John Laffey, Juliana Carvalho Ferreira, Oscar Penuelas, Marcus J. Schultz, Pien Swart, Luciano Azevedo, Hendrik Helmerhorst, Lukas Mueller-Wirtz, Elisa Estenssoro, Anissa Tsonas, Lieuwe Bos, Frederique Paulus, Emanuele Rezoagli(University of Milano-Bicocca), David van Meenen, Giacomo Bellani(University of Trento)
Cited by 0
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material
|Intensive Care Medicine|2012|1.5k
Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit
|The Lancet Respiratory Medicine|2014|1.3k
ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies
|Intensive Care Medicine|2023|855